×

Effective depletion of pre-existing anti-AAV antibodies requires broad immune targeting - 2017.pdf

Home / Discover /diyhpl.us/~bryan/papers2/gene-therapy/

  Parent Folder


Effective depletion of pre-existing anti-AAV antibodies requires broad immune targeting - 2017.pdf
PDF 4 years ago 2.32 MB
Copy Link   
Ectopic Catalase Expression in Mitochondria by Adeno-Associated Virus Enhances Exercise Performance in Mice.pdf
PDF 4 years ago 698.28 kB
Copy Link   
Efficient gene delivery to the adult and fetal CNS using pseudotyped non-integrating lentiviral vectors.pdf
PDF 4 years ago 1.00 MB
Copy Link   
Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein.pdf
PDF 4 years ago 438.03 kB
Copy Link   
Delivery technologies for genome editing - 2017.pdf
PDF 4 years ago 893.12 kB
Copy Link   
Emerging issues in AAV-mediated in vivo gene therapy - 2018.pdf
PDF 4 years ago 1.53 MB
Copy Link   
Current status of nonviral vectors for gene therapy in China - 2017.pdf
PDF 4 years ago 359.73 kB
Copy Link   
Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer.pdf
PDF 4 years ago 673.88 kB
Copy Link   
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.pdf
PDF 4 years ago 1.16 MB
Copy Link   
Engineering adeno-associated viruses for clinical gene therapy - 2015.pdf
PDF 4 years ago 624.99 kB
Copy Link   
Engineering targeted viral vectors for gene therapy - 2007.pdf
PDF 4 years ago 528.61 kB
Copy Link   
Construction of a Fully Retargeted Herpes Simplex Virus 1 Recombinant Capable of Entering Cells Solely via Human Epidermal Growth Factor Receptor 2.pdf
PDF 4 years ago 459.12 kB
Copy Link   
Cell penetrating peptides - overview and applications to the delivery of oligonucleotides.pdf
PDF 4 years ago 391.96 kB
Copy Link   
FDA Public Workshop on Cell and Gene Therapy - Agenda - November 2010.pdf
PDF 4 years ago 178.61 kB
Copy Link   
Cancer regression in patients after transfer of genetically engineered lymphocytes.pdf
PDF 4 years ago 571.71 kB
Copy Link   
Flushing out antibodies to make AAV gene therapy available to more patients - 2013.pdf
PDF 4 years ago 1.20 MB
Copy Link   
Gene doping - a review of performance-enhancing genetics.pdf
PDF 4 years ago 326.92 kB
Copy Link   
CNS-restricted transduction and CRISPR-Cas9-mediated gene deletion with an engineered AAV vector - 2016.pdf
PDF 4 years ago 5.18 MB
Copy Link   
CAV-2 - why a canine virus is a neurobiologist's best friend - 2015.pdf
PDF 4 years ago Get Size
Copy Link   
Gene therapy clinical trials worldwide 1989-2004.pdf
PDF 4 years ago 106.37 kB
Copy Link   

Join FilePursuit on FilePursuit Discord Server chat for discussions and more information.